The Vanguard Group 13D and 13G filings for Minerva Neurosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 08:27 am Sale | 2021-12-31 | 13G | Minerva Neurosciences, Inc. NERV | The Vanguard Group | 503,218 9.420% | -35,206 (-6.54%) | Filing |
| 2021-02-10 1:42 pm Purchase | 2021-01-29 | 13G | Minerva Neurosciences, Inc. NERV | The Vanguard Group | 538,424 10.090% | 7,164 (+1.35%) | Filing |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | Minerva Neurosciences, Inc. NERV | The Vanguard Group | 531,260 9.960% | 531,260 (New Position) | Filing |